Nanotherapy-mediated biased antigen-presenting cell reprogramming supports T cell anergy to prevent type 1 diabetes.
- DOI
- 10.64898/2026.10.21.760780
- Published
- 2026 Oct 23
- Container
- bioRxiv : the preprint server for biology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.64898/2026.10.21.760780,
title = {Nanotherapy-mediated biased antigen-presenting cell reprogramming supports T cell anergy to prevent type 1 diabetes.},
author = {Klug NR and Mbaye EHA and Wang S and Almunif S and Grace CR and Reda JW and Scariot DB and Yuk SA and Liu YG and Landrowski DH and Sharma S and Park H and Hubbell JA and Wasserfall CH and Scott EA and Burke JA},
year = {2026},
journal = {bioRxiv : the preprint server for biology},
doi = {10.64898/2026.10.21.760780},
url = {https://doi.org/10.64898/2026.10.21.760780}
}RIS
TY - JOUR TI - Nanotherapy-mediated biased antigen-presenting cell reprogramming supports T cell anergy to prevent type 1 diabetes. AU - Klug NR AU - Mbaye EHA AU - Wang S AU - Almunif S AU - Grace CR AU - Reda JW AU - Scariot DB AU - Yuk SA AU - Liu YG AU - Landrowski DH AU - Sharma S AU - Park H AU - Hubbell JA AU - Wasserfall CH AU - Scott EA AU - Burke JA PY - 2026 JO - bioRxiv : the preprint server for biology DO - 10.64898/2026.10.21.760780 UR - https://doi.org/10.64898/2026.10.21.760780 ER -
APA
NR, K., EHA, M., S, W., S, A., CR, G., JW, R., DB, S., SA, Y., YG, L., DH, L., S, S., H, P., JA, H., CH, W., EA, S., & JA, B. (2026). Nanotherapy-mediated biased antigen-presenting cell reprogramming supports T cell anergy to prevent type 1 diabetes.. bioRxiv : the preprint server for biology. https://doi.org/10.64898/2026.10.21.760780
Source records
- pubmed · retrieved 2026-11-10T11:47:14.170Z